Filing Details

Accession Number:
0001104659-21-076353
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-03 16:03:44
Reporting Period:
2021-06-01
Accepted Time:
2021-06-03 16:03:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613859 Pra Health Sciences Inc. PRAH Services-Commercial Physical & Biological Research (8731) 463640387
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1738327 J. Michael Bonello C/O Pra Health Sciences, Inc.
4130 Parklake Avenue, Suite 400
Raleigh NC 27612
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-01 4,823 $0.00 24,051 No 4 A Direct
Common Stock Disposition 2021-06-01 1,278 $170.45 22,773 No 4 S Direct
Common Stock Disposition 2021-06-01 906 $170.45 21,867 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2021-06-01 2,823 $0.00 2,823 $0.00
Common Stock Restricted Stock Unit Disposition 2021-06-01 2,000 $0.00 2,000 $0.00
Common Stock Restricted Stock Unit Acquisiton 2021-06-01 14,008 $0.00 14,008 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,647 No 4 M Direct
2,000 No 4 M Direct
14,008 No 4 A Direct
Footnotes
  1. Represents the vesting of two separate tranches of restricted stock units granted on June 1, 2020.
  2. Represents the number of shares required to be sold by the reporting person to satisfy tax withholding obligations related to the vesting of 2,823 restricted stock units from a June 1, 2020 grant of 8,470 restricted stock units which, upon vesting, convert into Issuer's common stock on a one-for-one basis under the PRA Health Sciences, Inc. 2020 Stock Incentive Plan. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  3. Represents the number of shares required to be sold by the reporting person to satisfy tax withholding obligations related to the vesting of 2,000 restricted stock units from a June 1, 2020 grant of 4,000 restricted stock units which, upon vesting, convert into Issuer's common stock on a one-for-one basis under the PRA Health Sciences, Inc. 2020 Stock Incentive Plan. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  4. Restricted stock units were granted on June 1, 2020 and convert into Issuer's common stock on a one-for one basis in an amount equal to one-third of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.
  5. Not applicable.
  6. Restricted stock units were granted on June 1, 2020 and convert into Issuer's common stock on a one-for one basis in an amount equal to 50% of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.
  7. Restricted stock units convert into the Issuer's common stock on a one-for-one basis in an amount equal to one-third of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.